Subject |
Standard-related technology in consumer electronics and telecommunications |
Genomic sequences SARS |
Medicines against HIV/AIDS |
R&D regarding NTDs |
SNPs related to nutrigenomics |
Diagnostic testing |
Nature |
Profit |
Non-profit |
Non-profit |
Hybrid |
Profit |
Profit |
Initiative |
Patent owners |
WHO/patent owners |
WHO/UNITAID |
GSK and other patent owners |
DSM |
MPEG LA |
Profile patent owners (public/private) |
Mainly private partners |
Mixed |
Mixed |
Mixed |
Mixed |
Mixed |
Main incentives |
Downstream, standards compatibility, opening up a market |
Upstream, humanitarian, quick and broad availability of vaccines |
Downstream, humanitarian, lower prices, combinations for specific populations |
Upstream, humanitarian, opening up a market, risk sharing |
Upstream, opening up a market, risk sharing |
Downstream, broad availability of tests, enabling personalized medicines, lower prices |
Administration pool |
One of the patent owners/independent third party, e.g. MPEG LA, VIA Licensing, SISVEL |
Unknown |
MPP |
BVGH/patent owners |
Independent third party |
MPEG LA |
Licensing practices |
Package license, essentiality standard, FRAND |
Package license |
Individual licenses |
Individual licenses, royalty-free, qualified participants |
Customized package license |
Customized package license |